Legal, Regulatory &
Forward-Looking Statements
Regulatory Notice:​
Regulatory Notice: PerioER™ and Periocin™ are candidate pre-commercial combination products. Core components of our mechanical delivery systems have been favorably classified by the FDA; however, the final drug-device combination products are subject to FDA Center for Drug Evaluation and Research (CDER) review and are not currently available for commercial sale in the United States. All information is provided for corporate, scientific, and investor evaluation purposes.
Investigational Status:​
PerioER™ and Periocin™ are investigational, pre-commercial candidate combination products. While certain mechanical device components may have received favorable regulatory classifications or exemptions, the final integrated drug-device products have not been proven safe or effective for their intended uses. They have not been approved, cleared, or licensed by the United States Food and Drug Administration (FDA) Center for Drug Evaluation and Research (CDER) or the FDA Center for Veterinary Medicine (CVM). Caution: Investigational New Drugs/Devices. Limited by Federal law to investigational use. They are not currently available for commercial sale, distribution, or clinical use in the United States or any other jurisdiction.
Forward-Looking Statement:​
Certain statements on this website, including those related to the anticipated development, regulatory approval pathways, commercialization, and market potential of PerioER™, Periocin™, and related proprietary technologies, constitute "forward-looking statements." These statements are based on current corporate expectations and involve known and unknown risks, uncertainties, and other factors that may cause actual results, performance, or regulatory timelines to differ materially from any future results expressed or implied by such statements. PharmaPhD II, LLC assumes no obligation to update these forward-looking statements to reflect events or circumstances after the date they are published.
Not an Offer to Sell Securities:​
The information provided on this website is for informational and strategic evaluation purposes only. It does not constitute an offer to sell, a solicitation of an offer to buy, or a recommendation for any security, investment, or acquisition of PharmaPhD II, LLC or its assets. Detailed financial, regulatory, and engineering data will only be provided to qualified entities under a fully executed Non-Disclosure Agreement (NDA).
No Medical or Veterinary Advice:​
The content provided on PharmaPhD.com is intended strictly for informational, corporate, and investor-relations purposes. It is not intended to be a substitute for professional medical, dental, or veterinary advice, diagnosis, or treatment. Patients and pet owners should always seek the advice of a qualified healthcare provider or licensed veterinarian with any questions regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of information read on this website.
Intellectual Property and Trademarks:​
PerioER™, Periocin™, and the PharmaPhD™ name and logo are trademarks of PharmaPhD II, LLC. The proprietary technologies, formulations, and mechanical architectures described herein are protected by pending and/or issued patents and trade secrets owned by PharmaPhD II, LLC. Unauthorized reproduction, reverse engineering, or commercial exploitation is strictly prohibited. Any other trademarks, registered trademarks, or brand names mentioned on this website are the property of their respective owners, and their use does not imply affiliation with, or endorsement by, those entities.